Clinical Trial Endpoint Solutions
philadelphia, pennsylvania, united states
1972
1001
Your score reflects how likely GenAI models are to trust this web service and mention it in responses to relevant prompts.
Sign in to see actionable suggestions tailored to your site's score.
TMO: Raised 2026 guidance after strong Q1, Clario acquisition, and robust pharma/biotech growth